2 completed, 1 terminated, 1 unknown, 1 withdrawn. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Terminated 1, Unknown 1, Withdrawn 1 |
Follow Adenoviral Conjunctivitis: new trials by email Literature Review of Adenoviral Conjunctivitis trials Research Report on Adenoviral Conjunctivitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis IVIEW-1201, Placebo - Adenoviral Conjunctivitis | Phase 2 | Completed | IVIEW Therapeutics Inc. | 135 | 2023-02-20 | 2025-10-15 |
| OKG-0301 for the Treatment of Acute Adenoviral Conjunctivitis OKG-0301 - Adenoviral Conjunctivitis | Phase 2 | Unknown | Okogen | 219 | 2019-02-11 | 2022-04-21 |
| Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240) Iota-Carrageenan, Carmellose - Adenoviral Conjunctivitis | Phase 2 | Withdrawn | NicOx | 2017-01-01 | 2017-05-10 | |
| Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis NVC-422 Solution, 0.3%, NVC-422 Vehicle Solution - Adenoviral Conjunctivitis | Phase 2 | Completed | NovaBay Pharmaceuticals, Inc. | 500 | 2012-05-01 | 2015-05-28 |
| An Evaluation of the Efficacy and Safety of AL-46383A Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis AL-46383A Ophthalmic Solution, AL-46383A Ophthalmic Solution Vehicle - Adenoviral Conjunctivitis | Phase 2 | Terminated | Alcon Research | 452 | 2009-06-01 | 2014-05-22 |
Conjunctivitis (2) · Adenoviridae Infections (1) · Eye Infections (1)
Conjunctival Diseases (2) · Eye Diseases (2) · Infections (2) · DNA Virus Infections (1) · Virus Diseases (1)
Carboxymethylcellulose Sodium (1) · Carrageenan (1)
Alcon Research (1) · IVIEW Therapeutics Inc. (1) · NicOx (1) · NovaBay Pharmaceuticals, Inc. (1) · Okogen (1)
India (2) · Australia (1) · Brazil (1) · Spain (1) · Sri Lanka (1) · United States (1)
Brigitte Duquesroix (1) · David Stroman, Ph.D. (1) · Sally Scheib (1)